Parkinsonism as a Third Wave of the COVID-19 Pandemic?
Open Access
- 22 September 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 10 (4) , 1343-1353
Abstract
Since the initial reports of COVID-19 in December 2019, the world has been gripped by the disastrous acute respiratory disease caused by the SARS-CoV-2 virus. There are an ever-increasing number of reports of neurological symptoms in patients, from severe (encephalitis), to mild (hyposmia), suggesting the potential for neurotropism of SARS-CoV-2. This Perspective investigates the hypothesis that the reliance on self-reporting of hyposmia has resulted in an underestimation of neurological symptoms in COVID-19 patients. While the acute effect of the virus on the nervous system function is vastly overshadowed by the respiratory effects, we propose that it will be important to monitor convalescent individuals for potential long-term implications that may include neurodegenerative sequelae such as viral-associated parkinsonism. As it is possible to identify premorbid harbingers of Parkinson’s disease, we propose long-term screening of SARS-CoV-2 cases post-recovery for these expressions of neurodegenerative disease. An accurate understanding of the incidence of neurological complications in COVID-19 requires long-term monitoring for sequelae after remission and a strategized health policy to ensure healthcare systems all over the world are prepared for a third wave of the virus in the form of parkinsonism.Keywords
This publication has 102 references indexed in Scilit:
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- Immunolocalization of Influenza A Virus and Markers of Inflammation in the Human Parkinson's Disease BrainPLOS ONE, 2011
- Unawareness of Olfactory Dysfunction and its Association with Cognitive Functioning in Middle Aged and Old AdultsArchives of Clinical Neuropsychology, 2011
- Use of ibuprofen and risk of Parkinson diseaseNeurology, 2011
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- NSAID Use and the Risk of Parkinsonʼs DiseaseDrugs & Aging, 2009
- Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 2009
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- The Review of “The relationship between encephalitis lethargica and influenza: A critical analysis”Journal of NeuroVirology, 2008
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007